Aromatherapy and Pain

Chronic Pain Clinical Trial

Official title:

The Effect of Aromatherapy on the Incidence and Severity of Post Procedure Pain and Discomfort in Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05910892
• Other study ID #: STUDY00007869
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2023
• Est. completion date: September 30, 2023

Study information

• Verified date: June 2023
• Source: University of Washington
• Contact: Lisa Y Flint
• Phone: 206 543-7817
• Email: lyflint[@]uw.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.

Description:

The study will explore the effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain. This will be a blinded study where patients will act as their own control over two treatment visits. On one visit patient will be exposed to either the aromatherapy or a placebo. On their second visit patients will be exposed to the other compound. The study will collect demographic data, pain intensity and affect, and catastrophizing information.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 25
• Est. completion date: September 30, 2023
• Est. primary completion date: September 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Have received at least one (1) prior IMS or trigger point injection treatment with researcher

• 18 years of age or older

• English language speaker

• has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit

• any analgesic medication taken must be consistent for both sessions

Exclusion Criteria:

• Non-English language speaker

• Age <18

• Allergy to essential oils

• Asthmatic

• Patient unable to self-administer aromatherapy

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Drug:
• Aromatherapy packet
5 deep breaths from packet prior to treatment
• Placebo packet
5 deep breaths from packet prior to treatment

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Washington

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Acute Pain	Examine the change in Acute Pain associated with two identical procedures involving muscle with either an aromatherapy intervention or control intervention. With each patient being their own control, patients will rate their acute pain immediately after the procedure on a 0-10 scale (0=No pain and 10=Pain as bad as you can imagine).	Immediately after the Procedure
Secondary	Change in Overall Experience	Examine the change in Overall Experience of pain with two identical procedures involving muscle with either an aromatherapy intervention or control intervention. With each patient being their own control, patients will rate their overall experience of pain after the procedure on a 0-10 scale (0=No pain and 10=Pain as bad as you can imagine).	Immediately after the Procedure